Analyst consensus rating
Disc Medicine Analyst Rating: Strong Buy
Direct answer
Disc Medicine's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $125.75.
Forecast evidence checked November 1, 2026.
Get free Disc Medicine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $80.84
- Average price target
- $125.75
- High price target
- $170.00
- Low price target
- $92.00
- Low target gap
- +13.8%
- Target upside
- +55.6%
- High target gap
- +110.3%
- Target range width
- 96.5%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- November 1, 2026
- Valid through
- November 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Disc Medicine?
Disc Medicine has a verified Strong Buy consensus. The same dataset has an average price target of $125.75.
How far are Disc Medicine's low and high targets from the recorded price?
The low target implies +13.8%, while the high target implies +110.3%.
How many analysts are included in Disc Medicine's consensus?
The verified consensus includes 12 analysts.
How is Disc Medicine's target upside or downside calculated?
The average target of $125.75 is divided by the recorded price of $80.84, then one is subtracted to produce +55.6%. This does not guarantee a future return.
When was Disc Medicine's analyst forecast verified?
The data was verified on 2026-11-01. The dataset is valid through 2026-11-08.